|
Epinephrine
(ep'' i nef' rin).
1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, (R)-. ( » Epinephrine contains not less than 97.0 percent and not more than 100.5 percent of C9H13NO3, calculated on the dried basis.
Packaging and storage
Preserve in tight, light-resistant containers.
Identification
To 5 mL of pH 4.0 acid phthalate buffer (see Buffer Solutions in the section Reagents, Indicators, and Solutions) add 0.5 mL of a slightly acid solution of Epinephrine (1 in 1000) and 1.0 mL of 0.1 N iodine. Mix, and allow to stand for 5 minutes. Add 2 mL of sodium thiosulfate solution (1 in 40): a deep red color is produced.
Specific rotation
Test solution:
20 mg per mL, in 0.6 N hydrochloric acid.
Loss on drying
Residue on ignition
Limit of adrenalone
Its absorptivity (see Spectrophotometry and Light-scattering
Limit of norepinephrine
Epinephrine standard solution
Dilute with methanol an accurately measured volume of a solution of USP Epinephrine Bitartrate RS in formic acid containing about 364 mg per mL to obtain a solution having a concentration of about 20 mg per mL.
Norepinephrine standard solution
Dilute with methanol an accurately measured volume of a solution of USP Norepinephrine Bitartrate RS in formic acid containing 16 mg per mL to obtain a solution having a known concentration of 1.6 mg per mL.
Test solution
Dissolve 200 mg of Epinephrine in 1.0 mL of formic acid, dilute with methanol to 10.0 mL, and mix.
Procedure
Apply 5-µL portions of Epinephrine standard solution, Norepinephrine standard solution, and Test solution to a suitable thin-layer chromatographic plate (see Chromatography
Assay
Dissolve about 300 mg of Epinephrine, accurately weighed, in 50 mL of glacial acetic acid, warming slightly if necessary to effect solution. Add crystal violet TS, and titrate with 0.1 N perchloric acid VS. Perform a blank determination, and make any necessary correction. Each mL of 0.1 N perchloric acid is equivalent to 18.32 mg of C9H13NO3.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 3052
Pharmacopeial Forum: Volume No. 37(2)
|